Repligen Corp (RGEN)
144.47
-2.07
(-1.41%)
USD |
NASDAQ |
Dec 20, 16:00
144.57
+0.10
(+0.07%)
After-Hours: 20:00
Repligen Profit Margin (Quarterly): -0.42% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| West Pharmaceutical Services Inc | 18.21% |
| QuidelOrtho Corp | -2.74% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | -17.98% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.41% |
| Return on Assets | -0.29% |
| Return on Invested Capital | -0.32% |
| Gross Profit Margin (Quarterly) | 50.03% |
| Operating Margin (Quarterly) | -5.06% |
| Return on Net Operating Assets | -0.41% |